Ignite Creation Date:
2025-12-25 @ 2:24 AM
Ignite Modification Date:
2026-01-18 @ 6:59 PM
Study NCT ID:
NCT07221734
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-10-28
First Post:
2025-10-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced [Unresectable or Metastatic] Melanoma
Sponsor:
mAbxience Research S.L.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-10
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-02
Completion Date Type:
ESTIMATED
First Submit Date:
2025-10-06
First Submit QC Date:
None
Study First Post Date:
2025-10-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-27
Last Update Post Date:
2025-10-28
Last Update Post Date Type:
ESTIMATED